SEC Form 4 · accession 0000899243-17-014587
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
May 24, 2017
Accepted (ET)
May 26, 2017 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.13 | May 24, 2017 | A | 90,000 | A | — | May 24, 2027 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period.